The CVHB937A12201 Study is looking to find out more about an investigational medication (called a study drug) in people with mild AD. We want to look at the study drug to see if it has an effect on a person’s ability to think and remember, and causes serious side effects.
To do this, the study will compare the effects of 2 different doses of the study drug with a placebo. If you take part, you will receive either the study drug or placebo. A placebo is a ‘dummy medication’ that does not contain any active medication. You will also have the opportunity to take part in a study extension period, in which all participants will receive the study drug.
